Eric Hao Ming Yang

Eric Hao Ming Yang is a Clinical Professor at the David Geffen School of Medicine, University of California, Los Angeles (UCLA). His clinical and research focus centers on Cardio-Oncology, with expertise in valvular disease, cardiac imaging, and cancer therapy-related cardiovascular toxicity. He is actively engaged in medical education and health disparities research.

Education/Training:

• M.D., University of Illinois at Chicago College of Medicine (2005)
• Internal Medicine Residency, Harbor-UCLA Medical Center (2008)
• Cardiovascular Diseases Fellowship, Harbor-UCLA Medical Center (2011)

Research Focus: Dr. Yang investigates cardiovascular complications in cancer patients, including chemotherapy-induced cardiotoxicity, immune checkpoint inhibitor myocarditis, and vascular disease. He emphasizes imaging applications (CT, echocardiography) and disparities in cardio-oncology outcomes. His work merges clinical care with translational research to optimize survivorship.

Publication Trends: Recent articles (2022-2025) highlight Cardio-Oncology guideline development, imaging innovations, and socioepidemiologic disparities. Dominant themes include SGLT2 inhibitor cardioprotection, immune-related toxicities, and procedural outcomes in high-risk populations like cancer survivors undergoing valve interventions.